Panaxia Pharmaceutical Industries Ltd
Panaxia is Israel's leading pharmaceutical manufacturer of unit-dose solid and liquid dosage form…
Panaxia is Israel's leading pharmaceutical manufacturer of unit-dose solid and liquid dosage forms, sterile injectables, and cannabis-based medical preparations authorised by the Israeli Ministry of Health. The Lod facility produces generic pharmaceuticals, hospital-use sterile bags, and medical cannabis oral formulations for domestic and export markets. ISO 13485 and EU GMP certified. International wholesale supply to pharmaceutical importers, hospital pharmacy systems, and licensed cannabis distribution networks in EU member states.
- Type
- Manufacturer
- Location
- Lod, Israel
- Founded
- 1947
- Website
- panaxia.co.il
- Categories
- Medical & Healthcare Supplies
- Markets
- Israel, Germany, Switzerland, Netherlands, United Kingdom
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-07 Mail server of the company domain
- debarment-clear (green), checked 2026-08-07 OpenSanctions
- sanctions-clear (green), checked 2026-08-07 OpenSanctions
- web-presence-since (green), checked 2026-08-04 Internet Archive (Wayback)
Claimed certifications
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
- ISO 13485, Medical Devices Quality IAF CertSearch
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)